Fogorvosi szemle, 2021 (114. évfolyam, 1-4. szám)

2021-03-01 / 1. szám

FOGORVOSI SZEMLE 114. évf. 1. sz. 2021. n 25 into various aspects of oral health. IntechOpen 2017; 61–67. https://doi.org/10.5772/intechopen.69957. 46. STONE H, MCNAB G, WOOD AM, STOCKLEY RA, SAPEY E: Variability of sputum inflammatory mediators in COPD and alpha1-antitrypsin deficiency. Eur Respir J 2012; 40 (3): 561–569. https://doi.org/10.1183/09031936.00162811 47. TAKEUCHI K, et al: Periodontal status and lung function decline in the community: the Hisayama Study. Sci Rep 2018; 8 (1): 13354. https://doi.org/10.1038/s41598-018-31610-3 48. VANFLETEREN LE, et al: Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187 (7): 728–735. https://doi.org/10.1164/rccm.201209-1665OC 49. VOGELMEIER, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: Tián T, gorzó i, ősze g, somFay a, raDnai m The importance of the relationship between chronic periodontitis and chronic obstructive pulmonary disease Review of literature Periodontitis is one of the most common human chronic inflammatory diseases and about 11% of adults develop its clini­cal signs. Untreated periodontitis ultimately leads to inflammation and destruction of the periodontium leading to the loss of the teeth. Periodontitis is considered as a dental focal infection. The foci can influence other diseases in different ar­eas of the body through different pathways. Diseases and conditions such as cardiovascular disease, diabetes mellitus, rheumatoid arthritis, gastric ulcer, pregnancy complications and respiratory diseases such as aspiration pneumonia and chronic obstructive pulmonary disease (COPD) have been proven to be affected by the condition of the periodontium. COPD is an inflammatory disease characterized by progressive deterioration of pulmonary function and increasing airway obstruction, including chronic bronchitis and emphysema. It has a worldwide prevalence in adults at the age of 40 years or older in about 9%–10%, and it is currently the third leading cause of death worldwide. In addition, the inci­dence and mortality of COPD are continually increasing. An observational study found that 97% of a COPD cohort had at least one other comorbidity, with 50% having at least four. This impacts the health care costs of COPD patients with multiple comorbidities that are 4,7 times higher than those with no comorbidity. As periodontitis and COPD are both chronic, progressive conditions characterized by neutrophilic inflammation with subsequent proteolytic destruction of connective tissue, it has been proposed that they share common pathophysiologic processes. Several mechanisms have been proposed to explain the association of periodontal disease and COPD. As summarized by the European Federation of Periodontology and American Academy of Periodontology (EFP/AAP), COPD inflammatory status may be modified either by aspiration of bacteria from the oral cavity and/or haematogenous dissemi­nation of inflammatory mediators and plaque organisms from periodontal pockets. The present review of literature aims to investigate the potential connection between periodontal disease and COPD. Keywords: chronic obstructive pulmonary disease, COPD, chronic periodontitis, focal infection, prevalence GOLD executive summary. Eur Respir J 2017; 49: 1750214. https://doi.org/10.1183/13993003.50214-2017 50. WANG Z, et al: Periodontal health, oral health behaviours, and chronic obstructive pulmonary disease. J Clin Periodontol 2009; 36: 750–755. https://doi.org/10.23937/2469-5734/1510062 51. ZHONG Y, SLADE GD, BECK JD, OFFENBACHER S: Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population. J Clin Periodontol 2007; 34 (4): 285–293. https://doi.org/10.1111/j.1600-051X.2007.01057.x 52. ZHOU X, HAN J, LIU Z, SONG Y, WANG Z, SUN Z: Effects of periodontal treatment on lung function and exacerbation frequency in patients with chronic obstructive pulmonary disease and chronic periodontitis: A 2-year pilot randomized controlled trial. J Clin Periodontol 2014; 41: 564–572. https://doi.org/10.1111/jcpe.12247 Review

Next

/
Thumbnails
Contents